Online citations, reference lists, and bibliographies.
← Back to Search

Biopolymer-Based Nanoparticles For Drug/Gene Delivery And Tissue Engineering

Sachiko Nitta, K. Numata
Published 2013 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
There has been a great interest in application of nanoparticles as biomaterials for delivery of therapeutic molecules such as drugs and genes, and for tissue engineering. In particular, biopolymers are suitable materials as nanoparticles for clinical application due to their versatile traits, including biocompatibility, biodegradability and low immunogenicity. Biopolymers are polymers that are produced from living organisms, which are classified in three groups: polysaccharides, proteins and nucleic acids. It is important to control particle size, charge, morphology of surface and release rate of loaded molecules to use biopolymer-based nanoparticles as drug/gene delivery carriers. To obtain a nano-carrier for therapeutic purposes, a variety of materials and preparation process has been attempted. This review focuses on fabrication of biocompatible nanoparticles consisting of biopolymers such as protein (silk, collagen, gelatin, β-casein, zein and albumin), protein-mimicked polypeptides and polysaccharides (chitosan, alginate, pullulan, starch and heparin). The effects of the nature of the materials and the fabrication process on the characteristics of the nanoparticles are described. In addition, their application as delivery carriers of therapeutic drugs and genes and biomaterials for tissue engineering are also reviewed.
This paper references
10.1155/2011/603098
Growth behaviors of ZnO nanorods grown with the sn-based bilayer catalyst-covered substrates
Dong-Hau Kuo (2011)
10.1016/S1359-0294(02)00082-1
Casein structure, self-assembly and gelation
D. Horne (2002)
10.1016/J.JCIS.2007.09.007
Self-assembly of β-casein and lysozyme
X. Pan (2007)
10.1016/j.ijpharm.2010.11.025
Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting.
L. F. Lai (2011)
10.3322/CA.2007.0003
Application of Nanotechnology in Cancer Therapy and Imaging
X. Wang (2008)
10.1021/bm300089a
Biocompatible and biodegradable dual-drug release system based on silk hydrogel containing silk nanoparticles.
K. Numata (2012)
10.1016/j.addr.2008.09.001
Polysaccharides-based nanoparticles as drug delivery systems.
Z. Liu (2008)
Formation and Properties of Chitosan—Cellulose Nanocrystal Polyelectrolyte−Macroion omplexes for Drug Delivery pplications
H. Wang (2011)
10.1016/j.ijpharm.2011.02.065
Chitosan nanoparticles as a dual growth factor delivery system for tissue engineering applications.
M. Rajam (2011)
10.1016/j.jconrel.2011.06.010
Design and cellular internalization of genetically engineered polypeptide nanoparticles displaying adenovirus knob domain.
Guoyong Sun (2011)
10.1016/J.LWT.2010.01.021
Chitosan application for active bio-based films production and potential in the food industry: Review
M. Aider (2010)
10.1038/jid.2009.149
Nitric oxide-containing nanoparticles as an antimicrobial agent and enhancer of wound healing.
R. Weller (2009)
10.1038/sj.gt.3302838
Gene therapy progress and prospects: non-viral gene therapy by systemic delivery
S. Li (2006)
10.1146/ANNUREV.PHYSCHEM.52.1.71
Surface biology of DNA by atomic force microscopy.
H. Hansma (2001)
10.1023/A:1016090420759
Evidence for Phospholipid Bilayer Formation in Solid Lipid Nanoparticles Formulated with Phospholipid and Triglyceride
H. Heiati (2004)
10.1007/s11095-008-9800-3
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
C. Vauthier (2008)
10.1016/J.JCONREL.2006.08.021
Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles.
K. L. Douglas (2006)
10.1021/BM015630N
Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system.
D. E. Meyer (2002)
10.1021/bc100596w
Mannosylated dextran nanoparticles: a pH-sensitive system engineered for immunomodulation through mannose targeting.
Lina Cui (2011)
10.1021/nl301529p
Digital switching of local arginine density in a genetically encoded self-assembled polypeptide nanoparticle controls cellular uptake.
Sarah R MacEwan (2012)
10.1016/j.jconrel.2011.11.015
Albumin: a versatile carrier for drug delivery.
K. Park (2012)
Nanoparticles-A Review. Tropical J. Pharm. Res
V Mohanraj (2006)
J. Microencapsul
10.1093/JAC/DKH478
Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?
F. Furno (2004)
10.1007/s11095-008-9710-4
Poly (lactide-co-glycolide)-Polymethacrylate Nanoparticles for Intramuscular Delivery of Plasmid Encoding Interleukin-10 to Prevent Autoimmune Diabetes in Mice
Ashwin Basarkar (2008)
10.1039/C1JM11163A
Hollow nanoparticles from zein for potential medical applications
H. Xu (2011)
10.1016/j.jconrel.2010.05.006
Gene delivery mediated by recombinant silk proteins containing cationic and cell binding motifs.
K. Numata (2010)
10.1021/LA048646I
Preparation and characterization of self-assembled nanoparticles of heparin-deoxycholic acid conjugates.
Kyeongsoon Park (2004)
10.1088/0957-4484/20/35/355101
Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
B. Mandal (2009)
10.1002/jbm.a.34051
Tamoxifen-loaded thiolated alginate-albumin nanoparticles as antitumoral drug delivery systems.
A. M. Martínez (2012)
10.1016/S0168-3659(97)00173-9
Preparation of chitosan self-aggregates as a gene delivery system.
K. Lee (1998)
10.1073/PNAS.95.8.4607
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.
S. Hobbs (1998)
10.1163/156856207779996931
Nanostructured materials for applications in drug delivery and tissue engineering
M. Goldberg (2007)
10.1016/J.JMB.2005.07.075
Structural basis of the drug-binding specificity of human serum albumin.
J. Ghuman (2005)
10.1007/S00396-007-1657-1
One-pot synthesis, characterization, and drug loading of polysaccharide-based nanoparticles with carboxy functional groups
H. Dou (2007)
10.1002/JCTB.3758
Fabrication and characterization of albumin‐acacia nanoparticles based on complex coacervation as potent nanocarrier
Rouhollah Hedayati (2012)
10.1016/J.TIFS.2005.12.011
Food protein-based materials as nutraceutical delivery systems
L. Chen (2006)
Nanotoxicology. Occup. Environ. Med
K Donaldson (2004)
10.1016/j.jconrel.2011.09.069
Impact of albumin on drug delivery--new applications on the horizon.
B. Elsadek (2012)
PREPARATION OF ALGINATE NANOPARTICLES BY DESOLVATION TECHNIQUE USING ACETONE AS DESOLVATING AGENT
A. Sailaja (2012)
Work in Brief
D. Loomis (2006)
10.1016/J.JCONREL.2004.10.001
Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release.
R. Herrero-Vanrell (2005)
10.1039/C1JM10188A
Amphiphilically-modified gelatin nanoparticles: Self-assembly behavior, controlled biodegradability, and rapid cellular uptake for intracellular drug delivery
W. Li (2011)
10.1007/S11434-007-0388-5
Dialdehyde starch nanoparticles: Preparation and application in drug carrier
Yu Danmi (2007)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
10.1080/10717540490280705
Chitosan Nanoparticles for Plasmid DNA Delivery: Effect of Chitosan Molecular Structure on Formulation and Release Characteristics
A. Bozkır (2004)
10.1080/026520400288427
Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake.
C. Coester (2000)
10.1016/j.ijpharm.2009.07.028
Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
N. Csaba (2009)
10.1016/S0378-5173(00)00590-1
Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups.
C. Weber (2000)
10.1016/S0168-3659(99)00156-X
Microstructure and release characteristics of the minipellet, a collagen-based drug delivery system for controlled release of protein drugs.
M. Maeda (1999)
10.2147/IJN.S5581
Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy
V. Gupta (2009)
10.1007/S11051-008-9549-Y
Biosynthesis of insulin-silk fibroin nanoparticles conjugates and in vitro evaluation of a drug delivery system
Haibo Yan (2008)
10.4155/fmc.09.111
Nitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery.
A. A. Eroy-Reveles (2009)
10.1016/0142-9612(87)90063-9
Fibroblast growth on a porous collagen sponge containing hyaluronic acid and fibronectin.
C. Doillon (1987)
10.1016/j.ijpharm.2009.12.052
Silk fibroin nanoparticles for cellular uptake and control release.
J. Kundu (2010)
10.1016/S0939-6411(03)00160-7
Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications.
J. Berger (2004)
10.1016/j.biomaterials.2008.12.066
In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery.
K. Sonaje (2009)
Bernkop-Schnürch, A. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: Synthesis and in vitro evaluation
M Roldo (2004)
10.1016/j.ejpb.2011.04.008
A new drug nanocarrier consisting of polyarginine and hyaluronic acid.
F. Oyarzun-Ampuero (2011)
10.1158/1078-0432.CCR-05-1634
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.
N. Desai (2006)
10.3109/02652049509051126
Collagen microparticles: preparation and properties.
B. Roessler (1995)
10.1016/J.JCONREL.2006.04.017
Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
M. George (2006)
10.1111/j.1440-1681.2006.04408.x
POLYMERIC CORE‐SHELL NANOPARTICLES FOR THERAPEUTICS
Y. Yang (2006)
10.1016/j.biomaterials.2009.02.036
Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy.
Y. Lin (2009)
10.1016/S0168-3659(01)00407-2
Chitosan-based nanoparticles for topical genetic immunization.
Z. Cui (2001)
10.1142/S0219581X09006080
FABRICATION AND EVALUATION OF HUMAN SERUM ALBUMIN (HSA) NANOPARTICLES FOR DRUG DELIVERY APPLICATION
Rabeah Mehravar (2009)
10.1016/S0169-409X(02)00228-4
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
J. Panyam (2003)
10.1088/2043-6262/3/2/025006
Biocompatible fluorescent zein nanoparticles for simultaneous bioimaging and drug delivery application
R. G. Aswathy (2012)
10.1016/J.ACTBIO.2007.07.007
Self-assembled elastin-like polypeptide particles.
J. Osborne (2008)
10.1007/s10847-011-9950-5
Chitosan/cyclodextrin nanoparticles as drug delivery system
H. Ammar (2011)
10.1016/j.biomaterials.2009.09.030
Self-assembled hyaluronic acid nanoparticles for active tumor targeting.
K. Choi (2010)
10.1016/S0378-5173(02)00548-3
Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles.
Y. Xu (2003)
10.1021/JF00003A001
Thermal gelation of globular proteins: influence of protein conformation on gel strength
C. Wang (1991)
10.1039/C0SM01332C
Highly efficient processing of silk fibroin nanoparticle-L-asparaginase bioconjugates and their characterization as a drug delivery system
Yu-qing Zhang (2011)
10.1166/JNN.2007.609
Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation.
B. Sarmento (2007)
10.3168/JDS.S0022-0302(06)72258-5
Stability of casein micelles cross-linked by transglutaminase.
M. Smiddy (2006)
10.1007/s00216-010-3737-1
Drug–protein binding: a critical review of analytical tools
Karine Vuignier (2010)
10.1016/S0168-3659(99)00248-5
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H. Maeda (2000)
10.1088/0957-4484/19/7/075105
Design of novel polysaccharidic nanostructures for gene delivery.
M. de la Fuente (2008)
10.1155/2011/646538
Surface modification of gelatin nanoparticles with polyethylenimine as gene vector
W. Kuo (2011)
10.2217/nnm.11.188
A novel nanoparticle delivery system for in vivo targeting of the sciatic nerve: impact on regeneration.
N. Gonçalves (2012)
10.1016/j.nano.2009.06.006
Beta-casein nanovehicles for oral delivery of chemotherapeutic drugs.
Alina Shapira (2010)
10.1166/JBN.2012.1354
Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model.
Anish Babu (2012)
10.1016/j.biomaterials.2010.02.024
Controlling silk fibroin particle features for drug delivery.
Andreas Lammel (2010)
10.1016/J.NANO.2005.06.004
Role of nanotechnology in targeted drug delivery and imaging: a concise review.
O. Koo (2005)
10.1023/A:1016064930502
Albumin Nanospheres as Carriers for Passive Drug Targeting: An Optimized Manufacturing Technique
B. Müller (2004)
10.1002/9780470944349.CH10
Modified Natural Polysaccharides as Nanoparticulate Drug Delivery Devices
A. Bhaw-Luximon (2010)
10.1016/j.juro.2010.11.091
Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy.
Z. Lu (2011)
10.1016/J.EJPB.2007.08.001
Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
M. Gaumet (2008)
10.1016/J.IDAIRYJ.2007.10.009
Structure and stability of nanogel particles prepared by internal cross-linking of casein micelles
T. Huppertz (2008)
10.1002/1521-4095(200008)12:15<1105::AID-ADMA1105>3.0.CO;2-1
Thermo‐Reversible Self‐Assembly of Nanoparticles Derived from Elastin‐Mimetic Polypeptides
T. T. Lee (2000)
Nitric oxide release: Part II
A. W. Carpenter (2012)
Hydrogel nanoparticles in drug
M. Hamidi (2008)
10.1016/j.jconrel.2011.07.031
Albumin-based nanoparticles as potential controlled release drug delivery systems.
Ahmed O Elzoghby (2012)
10.1002/JEMT.1070270609
Electron microscopy of the blood‐brain barrier in disease
A. Hirano (1994)
10.1155/2011/753705
Preparation of rhodamine B fluorescent poly(methacrylic acid) coated gelatin nanoparticles
Z. Gan (2011)
10.1016/j.jconrel.2012.04.036
Protein-based nanocarriers as promising drug and gene delivery systems.
Ahmed O Elzoghby (2012)
10.1039/c1cs15239d
Polysaccharides as building blocks for nanotherapeutics.
Shoshy Mizrahy (2012)
10.1007/s00449-011-0591-2
Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation
Eun Ju Lee (2011)
10.1038/nmat2859
Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.
D. S. Wilson (2010)
Rodrí guez-Cabello, J.C. Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release
R Herrero-Vanrell (2005)
10.4314/TJPR.V5I1.14634
Nanoparticles - A Review
V. Mohanraj (2007)
10.1016/j.ijbiomac.2011.05.020
Controlled release of tamoxifen citrate encapsulated in cross-linked guar gum nanoparticles.
J. K. Sarmah (2011)
10.1021/bm101584c
Formation and properties of chitosan-cellulose nanocrystal polyelectrolyte-macroion complexes for drug delivery applications.
Hezhong Wang (2011)
10.1016/S0168-3659(96)01605-7
Prolongation of the serum half-life period of superoxide dismutase by poly(ethylene glycol) modification
R. Nakaoka (1997)
10.1038/7385
Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy
K. Roy (1999)
10.2217/NNM.13.159
Hydrogel nanoparticles for drug delivery.
M. Dalby (2013)
10.1002/BIP.20539
Nanogels prepared by self-assembly of oppositely charged globular proteins.
S. Yu (2006)
10.1016/J.ADDR.2006.03.001
Natural polymers for gene delivery and tissue engineering.
Jiyoung M Dang (2006)
10.1016/j.addr.2010.03.009
Silk-based delivery systems of bioactive molecules.
K. Numata (2010)
10.1016/S0378-5173(99)00370-1
Desolvation process and surface characterisation of protein nanoparticles.
C. Weber (2000)
10.1111/J.1745-4549.2009.00390.X
ENCAPSULATION OF FISH OIL IN SOLID ZEIN PARTICLES BY LIQUID‐LIQUID DISPERSION
Q. Zhong (2009)
10.1016/j.nano.2008.07.007
Targeting of albumin-embedded paclitaxel nanoparticles to tumors.
P. Karmali (2009)
10.1016/j.drudis.2012.01.016
Auto-associative amphiphilic polysaccharides as drug delivery systems.
L. Hassani (2012)
10.1016/S0169-409X(00)00124-1
Block copolymer micelles for drug delivery: design, characterization and biological significance.
K. Kataoka (2001)
10.1021/BC060098S
Surface modification of poly(L-lactic acid) membrane via layer-by-layer assembly of silver nanoparticle-embedded polyelectrolyte multilayer.
D. Yu (2007)
10.1016/J.CARBPOL.2011.09.044
Recent applications of starch derivatives in nanodrug delivery
A. Rodrigues (2012)
10.3390/ma3031863
Collagen-Based Biomaterials for Tissue Engineering Applications
R. Parenteau-Bareil (2010)
10.1080/10408699891274354
Structure and technofunctional properties of protein-polysaccharide complexes: a review.
C. Schmitt (1998)
10.1002/wnan.66
Nanomaterial standards for efficacy and toxicity assessment.
Pavan P. Adiseshaiah (2010)
10.1016/j.jconrel.2009.08.012
Nanoparticles made from novel starch derivatives for transdermal drug delivery.
M. J. Santander-Ortega (2010)
10.1016/j.jconrel.2011.02.010
Casein-based formulations as promising controlled release drug delivery systems.
Ahmed O Elzoghby (2011)
10.1021/bm101055m
Silk-based gene carriers with cell membrane destabilizing peptides.
K. Numata (2010)
10.1016/S0378-5173(01)00760-8
Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
A. M. de Campos (2001)
10.1016/J.POLYMER.2005.11.091
One-step synthesis of dextran-based stable nanoparticles assisted by self-assembly
Minhua Tang (2006)
10.1021/nl300630c
Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution.
Daniel J. Callahan (2012)
10.1021/MA990408K
Aggregation in Water of Dextran Hydrophobically Modified with Bile Acids
M. Nichifor (1999)
10.1016/j.biomaterials.2008.07.001
Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation.
I. Steinhauser (2008)
10.1002/mabi.201100244
A hydrophobic starch polymer for nanoparticle-mediated delivery of docetaxel.
Prajakta Dandekar (2012)
10.1021/JF060119C
Micellization of bovine β-casein studied by isothermal titration microcalorimetry and cryogenic transmission electron microscopy
I. Portnaya (2006)
10.1016/S0169-409X(02)00059-5
Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences.
E. Wright (2002)
10.1056/NEJM197603042941005
Drug therapy. Binding of drugs to serum albumin (second of two parts).
J. Koch-weser (1976)
10.1021/bm901428y
Starch nanoparticles: a review.
Déborah Le Corre (2010)
10.1021/bm201401s
Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image.
Guangming Gong (2012)
10.1021/bm2003384
pH-responsive polysaccharide-based polyelectrolyte complexes as nanocarriers for lysosomal delivery of therapeutic proteins.
M. I. Giannotti (2011)
10.1016/j.biomaterials.2009.12.043
The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.
K. K. Upadhyay (2010)
10.1007/s00592-011-0356-z
Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy
Ying-zheng Zhao (2011)
10.2174/092986712800784658
Polysaccharide-based nanoparticles: a versatile platform for drug delivery and biomedical imaging.
G. Saravanakumar (2012)
10.1039/c2cs15273h
Nitric oxide release: part II. Therapeutic applications.
A. W. Carpenter (2012)
10.1002/APP.27078
Chitosan nanoparticles for loading of toothpaste actives and adhesion on tooth analogs
H. Liu (2007)
10.1038/nrd2591
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
10.1021/nl102184c
Nanotechnology in drug delivery and tissue engineering: from discovery to applications.
J. Shi (2010)
10.1016/J.CARBPOL.2011.10.030
Targeted delivery of paclitaxel using folate-conjugated heparin-poly(β-benzyl-l-aspartate) self-assembled nanoparticles
L. Li (2012)
10.1021/bc200170u
Spider silk-based gene carriers for tumor cell-specific delivery.
K. Numata (2011)
10.1016/S0378-5173(03)00134-0
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
K. Langer (2003)
10.1016/0169-409X(95)00043-7
Mechanisms of splenic clearance of blood cells and particles : towards development of new splenotropic agents
S. Moghimi (1995)
10.1177/0091270004269646
Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin
D. Bosse (2005)
10.1016/S0378-5173(97)00149-X
Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process
E. Leo (1997)
10.1016/J.EJPS.2006.12.007
Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
C. Reis (2007)
10.3109/02652048.2011.635219
Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumour targeting
A. Jain (2012)
10.1016/S0169-409X(02)00044-3
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
10.1166/JBN.2010.1137
Preparation of zein nanoparticles by pH controlled nanoprecipitation.
S. Podaralla (2010)
10.1016/j.jconrel.2008.05.010
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
10.1016/j.ejpb.2011.10.022
β-Casein nanoparticle-based oral drug delivery system for potential treatment of gastric carcinoma: stability, target-activated release and cytotoxicity.
Alina Shapira (2012)
10.1021/bm801513e
Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan.
Soheil Boddohi (2009)
10.1016/J.FOODHYD.2009.06.015
Zein nanoparticles produced by liquid-liquid dispersion.
Q. Zhong (2009)
10.1002/MASY.200550113
Calcium‐Alginate Nanoparticles Formed by Reverse Microemulsion as Gene Carriers
Jin-Oh You (2005)
10.1016/j.biomaterials.2009.06.028
Bioengineered silk protein-based gene delivery systems.
K. Numata (2009)
10.1002/jbm.a.32117
Novel gene-activated matrix with embedded chitosan/plasmid DNA nanoparticles encoding PDGF for periodontal tissue engineering.
L. Peng (2009)
10.1021/bc1002295
Targeted albumin-based nanoparticles for delivery of amphipathic drugs.
Rongzuo Xu (2011)
10.1016/j.carbpol.2012.03.010
Chitosan/carrageenan nanoparticles: effect of cross-linking with tripolyphosphate and charge ratios.
Susana Rodrigues (2012)
10.1016/S0939-6411(03)00155-3
Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy.
Sania Mansouri (2004)
10.1016/j.colsurfb.2011.03.008
In situ synthesis of polysaccharide nanoparticles via polyion complex of carboxymethyl cellulose and chitosan.
S. Kaihara (2011)
10.1016/S0168-3659(98)00017-0
Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin.
K. Akiyoshi (1998)
10.1007/S11051-011-0327-X
Controlled self assembly of collagen nanoparticle
M. Papi (2011)
10.1016/j.tibtech.2008.03.001
Nanotechnology in vascular tissue engineering: from nanoscaffolding towards rapid vessel biofabrication.
V. Mironov (2008)
10.1002/PI.3056
Chitosan nanoparticles: a contribution to nanomedicine
H. Peniche (2011)
10.1016/J.REACTFUNCTPOLYM.2008.03.002
Chitosan-modifications and applications: Opportunities galore
V. Mourya (2008)
10.1016/j.biomaterials.2011.10.005
Targeted non-covalent self-assembled nanoparticles based on human serum albumin.
A. Bunschoten (2012)
10.1016/J.BIOMATERIALS.2007.06.025
Elastin as a biomaterial for tissue engineering.
W. Daamen (2007)
Nanoparticles--a new colloidal drug delivery system.
J. Marty (1978)
Schindel, F. Phase I comparability of recombinant human albumin and human serum albumin
D Bosse (2005)
10.1002/mabi.201000427
Self-assembly strategy for the preparation of polymer-based nanoparticles for drug and gene delivery.
S. Chen (2011)
10.1021/bm201165h
Tunable self-assembly of genetically engineered silk--elastin-like protein polymers.
Xiao-Xia Xia (2011)
10.1016/S0169-409X(00)00123-X
Polysaccharide colloidal particles as delivery systems for macromolecules.
K. Janes (2001)
10.1002/jcb.20796
Engineered nanoparticles as precise drug delivery systems
T. C. Yih (2006)
10.1016/S0939-6411(98)00017-4
Collagen--biomaterial for drug delivery.
W. Frieß (1998)
10.1016/j.ijpharm.2012.04.048
Paclitaxel-incorporated nanoparticles of hydrophobized polysaccharide and their antitumor activity.
S. Lee (2012)
10.1039/b909897f
Stimuli-responsive nanoparticles composed of naturally occurring amphiphilic proteins.
N. Kamiya (2009)
10.1021/BM0502258
Preparation and characterization of chitosan-based nanoparticles.
Magdolna Bodnár (2005)
10.1016/S0169-409X(02)00060-1
Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery.
A. Chilkoti (2002)
10.1021/JA043920G
Reversible inside-out micellization of pH-responsive and water-soluble vesicles based on polypeptide diblock copolymers.
J. Rodríguez-Hernández (2005)
10.1007/s00253-003-1321-8
Non-viral gene therapy: polycation-mediated DNA delivery
M. Thomas (2003)
10.1016/j.niox.2008.04.003
Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites.
A. Friedman (2008)
10.1016/S0939-6411(03)00157-7
Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation.
M. Roldo (2004)
10.1056/NEJM197602052940605
Binding of Drugs to Serum Albumin
J. Koch-weser (1976)



This paper is referenced by
10.3390/COATINGS9070454
Surface Modification of Hemoglobin-Based Oxygen Carriers Reduces Recognition by Haptoglobin, Immunoglobulin, and Hemoglobin Antibodies
Ausanai Prapan (2019)
10.1201/B19038-32
Cellulose-Based Biopolymers
John Dike Ogbonna (2015)
10.6515/ACS20141114A
Effects of Tissue-Type Plasminogen Site-Specific Transgene in Gelatin-Coated Dacron on the Fibrinolysis Activity of Rabbit Left Atrium.
Xiaobin Liu (2015)
10.5772/INTECHOPEN.68434
Green Intelligent Nanomaterials by Design (Using Nanoparticulate/2D-Materials Building Blocks) Current Developments and Future Trends
D. Kumar (2017)
10.1186/s12951-014-0033-9
Activation of caspase-dependent apoptosis by intracellular delivery of cytochrome c-based nanoparticles
Moraima Morales-Cruz (2014)
10.1016/j.ultsonch.2016.05.037
Physiochemical and cytotoxicity study of TPGS stabilized nanoemulsion designed by ultrasonication method.
K. Kaur (2017)
10.1021/acs.nanolett.8b03837
Active Targeting of Cancer Cells by Nanobody Decorated Polypeptide Micelle with Bio-orthogonally Conjugated Drug.
S. A. Costa (2019)
10.1007/978-3-030-44552-2_8
Nanotechnology Applications to Improve Solubility of Bioactive Constituents of Foods for Health-Promoting Purposes
Silvana Alfei (2020)
10.1088/1361-6528/aabecc
Controlled release of 18-β-glycyrrhetic acid by nanodelivery systems increases cytotoxicity on oral carcinoma cell line.
I. Cacciotti (2018)
10.1016/j.jconrel.2014.06.016
Controlled release from recombinant polymers.
R. Price (2014)
10.15171/PS.2017.14
Natural Polysaccharide based Nanoparticles for Drug/Gene Deliv­ery
S. Salatin (2017)
10.1002/adhm.201900506
Soft-Nanoparticle Functionalization of Natural Hydrogels for Tissue Engineering Applications.
K. Elkhoury (2019)
10.1081/E-ENN3-120051984
Surface-Modified Nanoparticles to Improve Drug Delivery
Felipe A Oyarzun-Ampuero (2014)
10.1007/978-3-319-41129-3_5
Marine Polysaccharides Based Nano-Materials and Its Applications
S. Bhatia (2016)
10.1016/j.jddst.2020.101994
Guar gum micro-vehicle mediated delivery strategy and synergistic activity of thymoquinone and piperine: An in vitro study on bacterial and hepatocellular carcinoma cells
Sanghita Das (2020)
10.7150/thno.27313
Water-Mediated Nanostructures for Enhanced MRI: Impact of Water Dynamics on Relaxometric Properties of Gd-DTPA
Franca De Sarno (2019)
10.1016/J.FOODHYD.2015.05.006
Production of water soluble quercetin formulations by pressurized ethyl acetate-in-water emulsion technique using natural origin surfactants
V. Gonçalves (2015)
10.1016/j.fct.2017.11.007
Nanoencapsulated Illicium verum Hook.f. essential oil as an effective novel plant-based preservative against aflatoxin B1 production and free radical generation.
A. K. Dwivedy (2018)
10.1016/j.jconrel.2016.05.043
Solid nano‐in‐nanoparticles for potential delivery of siRNA
Orit Amsalem (2017)
10.1021/acs.jafc.5b00794
Stable nanoparticles prepared by heating electrostatic complexes of whey protein isolate-dextran conjugate and chondroitin sulfate.
Qingyuan Dai (2015)
10.2174/1573411014666180917110650
A Review for the Synthesis of Silk Fibroin Nanoparticles with Different Techniques and Their Ability to be Used for Drug Delivery
Olga Gianak (2019)
10.3390/nano9030459
Cholic Acid-Conjugated Methylcellulose-Polyethylenimine Nano-Aggregates for Drug Delivery Systems
T. Kim (2019)
10.1007/978-981-15-2063-1_12
Smart Biopolymeric Nanocarriers for Drug Delivery Applications
Preetam Bala (2020)
10.1186/s12951-020-00628-z
Facile synthesis and nanoscale features of a nanostructured nordihydroguaiaretic acid analog for therapeutic applications
G. S. M. John (2020)
10.1007/978-3-319-50654-8_15
Green Synthesis of Nanoparticles: An Emerging Phytotechnology
G. Awasthi (2017)
10.1007/978-3-319-59997-7_6
Bioprospecting Studies: Transforming the Natural Genetic Heritage into Biotechnological Richness
T. C. Maester (2017)
10.1016/j.jconrel.2017.03.023
Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5‐fluorouracil: In vitro and ex vivo studies
P. Sahu (2017)
10.1016/j.ijbiomac.2016.12.087
Pectin-zinc-chitosan-polyethylene glycol colloidal nano-suspension as a food grade carrier for colon targeted delivery of resveratrol.
Hashem Andishmand (2017)
10.1039/c4bm00369a
Drug and gene co-delivery systems for cancer treatment.
Z. Yang (2015)
10.4018/978-1-4666-5824-0.CH007
Pharmacokinetics of Polymeric Nanoparticles at Whole Body, Organ, Cell, and Molecule Levels
M. Li (2014)
NATURAL POLYSACCHARIDE BASED NANOPARTICLES FOR DRUG/GENE DELIVERY (REVIEW ARTICLE)
Salatin Sara (2017)
10.1002/APP.46643
Zein nanoparticle‐embedded electrospun PVA nanofibers as wound dressing for topical delivery of anti‐inflammatory diclofenac
Sama Ghalei (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar